“Swiss-Made” Direct Debits for Europe - SIX Group Launches new SEPA Service for the European MarketZURICH and FRANKFURT, Germany - SIX Group, the Swiss financial market infrastructure provider, will offer a SEPA-compatible direct debit service in cooperation with the SECB Swiss Euro Clearing Bank, Frankfurt, starting November 2, 2009. The offer is aimed at financial institutions in Switzerland and 30 other countries within the Single Euro Payments Area (SEPA) that would like to offer their customers the option of collecting standardized euro direct debits throughout Europe. Helsinn Announces New Plans for its Manufacturing OperationsLUGANO, Switzerland - Today the Swiss pharmaceutical group Helsinn announced new plans aimed at creating a competitive Manufacturing Organization focused on highly potent compounds, with strong R&D and production capabilities. Both financial investments and a new organization of the manufacturing sites in Ireland and Switzerland are part of this strategy. Cotecna Appointed by KSO SCISI for Indonesia Iron or Steel InspectionsGENEVA - Cotecna, one of the world’s leading international trade inspection, security and certification companies, has been officially appointed by Indonesia’s KSO SCISI, to handle the inspection of iron or steel shipments from Korea and Japan to Indonesia. New Data From CLARITY Study Presented at 19th ENS Meeting Show Rapid and Sustained MS Relapse Reduction for Cladribine TabletsMILAN, Italy and GENEVA, Switzerland - The Effect of Short-course Oral Treatment With Cladribine Tablets on Annualized Relapse Rate was Significant as Early as 12 Weeks After Initiation of Treatment and Sustained Through to the 96 Weeks of the Study Original or Copy?SEVELEN, Switzerland - Textil-DNA From Schoeller Can Reveal Within Seconds The damage resulting from counterfeit products worldwide is estimated at euro 200 to 300 billion*. It is no longer just a question of copying good designs. Fakes and copies of technical products call the safety of these products into question and, consequently, product liability claims are increasing. At Techtextil in Frankfurt, the Swiss technology company, Schoeller, presented the Textil-DNA project for the first time. WISeKey Lands CH 4.5 Million in Anti-Counterfeiting and New Generation Digital Identification Technology ContractsGENEVA, Switzerland - WISeKey SA announced today it has received orders in June totaling CHF 4.5 million from several clients from its anti-counterfeiting and Digital Identity system that safeguards and verifies the authenticity of luxury goods and protects the digital identity of users. Launch of www.Radostar.comLENGNAU, Switzerland - The iconic Swiss watchmaker Rado, a key media partner at Salone del Mobile 2009, made full use of the event in Milan to officially launch its exciting new initiative, www.radostar.com. NewClassic, the new Balances of METTLER TOLEDO Help Users Create Lasting ValueGREIFENSEE, Switzerland - New Enhanced Functionalities Offer Users Immediate Results, Easier Handling and More Opportunities to Speed up Their Weighing Processes Microlife WatchBP Invites Medical Professionals for a ‘New way through together’ at ESH MeetingWIDNAU, Switzerland - By Guideline-Based Solution for Blood Pressure Measurement — Microlife WatchBP(R) WHO and EFA Call for Global Action on Chronic Respiratory DiseaseROME - Call to Reduce the Four Million Deaths Annually, From a Condition Responsible for More Fatalities Globally Than AIDS[1] 50,000 Euro RapidShare Lottery Prize Goes to IndiaCHAM, Switzerland - RapidShare AG, a popular 1-click-hoster, has today announced the winner of its RapidShare Lottery. Over 500,000 people took part in the prize draw by exchanging RapidPoints for raffle tickets. And the winner is 19 year old Srishti A. from India. Bobby Chang, COO of RapidShare AG, will be presenting her with the prize and congratulating the young Indian in person at the beginning of July. RapidShare Makes Interface to Application Programming AccessibleCHAM, Switzerland - RapidShare AG, one of the most popular 1-Click-Hosters, has released its application programming interface (API). This will enable private and professional developers to incorporate RapidShare technology quickly and easily into their tools and integrate upload functions in music and video software or games, for example. In addition, they will also be able to write programs to manage RapidShare accounts - there are no limits to coders’ ideas. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain BarrierNOVATO, California - Roche to fund evaluation of Raptor’s proprietary NeuroTrans(TM) technology SuccessFactors Wins Deployment at Siemens AG With 420,000 UsersMUNICH - SuccessFactors Will Enable 420,000 Siemens Users across 80 Countries in 20 Languages to be Unified and Linked in One System to Executive Strategy, Driving the Next Paradigm of Superior Business Execution ADM to Present at Deutsche Bank - Global Consumer & Food Retail ConferenceROLLE, Switzerland - Archer Daniels Midland Company (NYSE: ADM) will participate in the Deutsche Bank Global Consumer & Food Retail Conference in Paris, France, on Wednesday, June 10, 2009. Steve Mills, executive vice president and chief financial officer, and John Rice, executive vice president, commercial and production, will present at 1:45 p.m. Central European Summer Time (7:45 a.m. Eastern Time). First Phase III Clinical Trial Results of Safinamide in Advanced Parkinson’s Disease to Be Presented at the Movement Disorder Society 13th International CongressGENEVA, Switzerland - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals S.p.A. (SWX: NWRN) announced today that detailed results of the first Phase III clinical trial of safinamide as adjunctive treatment in mid- to late-stage Parkinson’s disease (PD) (Study 016) will be presented at the Movement Disorder Society’s 13th International Congress of Parkinson’s Disease and Movement Disorders to be held in Paris, France, from June 7-11, 2009. One-Year Phase III Study Confirms Ilaris(R) Offers Long-Term Remission in Patients With CAPS, a Severe Lifelong Auto-Inflammatory DiseaseBASEL, Switzerland - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)(1) Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for CystinosisNOVATO, California - Raptor Pharmaceuticals Corp. (”Raptor” or the “Company”) (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University of California, San Diego (”UCSD”), to evaluate Raptor’s proprietary delayed-release cysteamine bitartrate (”DR Cysteamine”) capsules in nephropathic cystinosis (”cystinosis”), a rare genetic lysosomal storage disease. Under Raptor’s open Investigational New Drug application (”IND”), UCSD is performing the Raptor-sponsored trial at its General Clinical Research Center. World Heart Federation Warns that Burden of Tobacco Epidemic Continues to Worsen Societies and EconomiesGENEVA - 6 Million People will die and $500 Billion Lost G-20 leaders pledged to provide the International Monetary Fund with $500 billion to help struggling economies, sparking global controversy. Yet startling research shows that the combined costs of tobacco-related death and related productivity losses, healthcare expenditures, employee absenteeism, and widespread environmental harm are responsible for draining the same amount - $500 billion - from the global economy each year and it receives much less attention than it deserves. ADM Completes Acquisition of German Chocolate ManufacturerROLLE, Switzerland - Archer Daniels Midland Company (NYSE: ADM) announced today that is has completed the acquisition of the Schokinag-Schokolade-Industrie Herrmann GmbH & Co. KG, following approval by relevant antitrust authorities. The acquisition was announced on January 23, 2009. Global Study Reveals Post Liberalisation Disasters in EuropeNYON, Switzerland - Postal market liberalisation routinely leads to unemployment, attacks on working conditions and poorer service for customers, says a study released today by UNI Global Union. Merck Serono to Support First International Thyroid Awareness WeekGENEVA, Switzerland - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that in the frame of the first International Thyroid Awareness Week, from May 25 to 31, the company in cooperation with Thyroid Federation International (TFI) will launch an awareness campaign, also supported by the European Thyroid Association (ETA) and the Latin American Thyroid Society (LATS), to raise awareness of thyroid dysfunctions and their consequences, in approximately 40 countries worldwide. Together with the international patient organization TFI, Merck Serono will provide information on these under-diagnosed diseases through professional educational sessions and distribution of information to the public. These materials will be distributed in several languages and are available online for download. Hawker Beechcraft Sets Industry Standard for SustainabilityGENEVA - Hawker Beechcraft Corporation (HBC) is taking the lead in sustainability among aircraft manufacturing companies. HBC organized the formation of the Wichita Sustainability Coalition, implemented a sustainability program throughout all areas of its business and expanded its company recycling program. In addition, the Beechcraft Bonanza G36 was the first to fly on Swift Sustainable Fuel and among the first to fly on unleaded fuel. Seven-Time PGA Event Champion Sergio Garcia Takes Ceremonial Delivery of First-In-Class Hawker 4000GENEVA - Golf champion touts world’s most advanced business jet at EBACE Hawker Beechcraft Corporation (HBC) announced that seven-time PGA Event Champion Sergio Garcia took ceremonial delivery of the revolutionary Hawker 4000 super-midsized business jet on May 12 at the European Business Aviation Convention and Exhibition (EBACE) in Geneva, Switzerland. The Hawker 4000 is first in its class, first in the world and the most advanced business jet in the world based on its innovative composite construction. Phase III Data Show Novartis Investigational Bronchodilator QAB149 Significantly Improves Lung Function Over Current Treatments in COPD[1,2]BASEL, Switzerland - **This press release is not intended for the UK media** - Once daily QAB149 (indacaterol) significantly improves lung function compared to formoterol and tiotropium, two currently approved COPD treatments, at three months of treatment[1,2] - Pending approval, QAB149 could be the first once-daily bronchodilator to combine clinically relevant 24-hour bronchodilation with onset of action within five minutes[3,4,5] - All doses of QAB149 are well-tolerated with a good overall safety profile in three pivotal trials: INVOLVE (1 year), INHANCE (6 months) and INLIGHT-1 (3 months)[4,5,6] - COPD, a debilitating and progressive respiratory disease, is a leading and growing cause of death that affects 210 million people worldwide[7] Merck Serono Committed to Investing in Innovation in the Fertility AreaGENEVA, Switzerland - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, confirms its commitment to investing in the therapeutic area of fertility, after Merck KGaA informed earlier today the Oslo Stock Exchange of its withdrawal of the voluntary cash tender offer for MediCult A/S, a leader in Assisted Reproductive Technologies (ART), as the required share threshold was not reached in the set timeframe. World Health Assembly Forced to Postpone Decision on Viral HepatitisGENEVA, Switzerland - Global Epidemic Kills One Person Every 30 Seconds and One Million People Will Die Before the World Health Assembly Meets Again in 2010 Obama & Co. as Figures of Fun: Leading Cartoonist Portrays Over 150 of the World’s Best-Known PersonalitiesSOLOTHURN, Switzerland - Picture is available via EPA (European Pressphoto Agency) and can be downloaded free of charge at: www.presseportal.ch/de/pm/100017384 Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson’s DiseaseGENEVA, Switzerland - Additional Important Effects of Safinamide Noted in Ongoing Analyses of First Phase III Clinical Trial Done in Similar Patient Population (study 016) green.ch Plans the Construction of a New greenDatacenterBRUGG, Switzerland - Plans for an Area Covering Over 10,000 m2 and a Modern Office Block - Note:Picture will be distributed Europe-wide and can be downloaded under: www.presseportal.ch/de/pm/100009189 - ACM Awarded “Best Online Currency Trading Services”!GENEVA - In April 2009, ACM (ac-markets.com) was awarded “Best Online Currency Trading Services” by World Finance at the London Stock Exchange Viroblock SA Reports a 99% Boost of Efficacy of Facemasks Against H5N1PLAN-LES-OUATES, Switzerland - Viroblock SA announces that its antiviral products boosts the efficacy of facemasks by at least 99.0%, i.e. 100 times better and a peak performance of 1000 times, against avian influenza virus H5N1. Disposable facemasks are thus far not very effective against viruses, such as influenza, whose sizes are 0.02 to 0.3 microns. Banco Bradesco S.A. Announces First Quarter 2009 Earnings ResultsSAO PAULO - Banco Bradesco S.A. (NYSE: BBD) announces 1st Quarter 2009 Earnings Results. The main figures obtained by Bradesco in 1Q09 are presented below: Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company OctapharmaLACHEN, Switzerland - Company Working With Authorities to Ensure Adequate Supply of Virally Inactivated Plasma Derivatives WISeKey’s Identity Semantics Suite Enables Pan-European eID Interoperability With Microsoft’s Citizen Services PlatformGENEVA and REDMOND, Washington - WISeKey today announced its partnership with Microsoft to deploy its Identity Semantics Suite with Microsoft’s Citizen Services Platform (CSP). The combination makes it easy for local, regional and national governments to deal with the complexity of identity systems and identity credentials that they are or will be required to accept as part of, for example, the European Services Directive (requiring a one-stop-shop treatment for businesses through electronic means). Citizens and enterprises will be able to use existing or new electronic identity credentials that are legally accepted, to transact across borders with governments. |
